Actively Recruiting
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
Led by National Cancer Centre, Singapore · Updated on 2026-05-13
5500
Participants Needed
1
Research Sites
847 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.
CONDITIONS
Official Title
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed histological diagnosis of solid tumor
- Suitable for systemic treatment and clinical trials
- Eastern Cooperative Oncology Group (ECOG) performance status less than 2
- Able to provide tumor tissue for molecular profiling
- Able to understand and sign the informed consent form
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cancer Centre, Singapore
Singapore, Singapore
Actively Recruiting
Research Team
D
Daniel SW Tan
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here